About FMS Dividend Returns
Fresenius Medical Care AG & Co. KGaA (FMS) is a dividend-paying stock. When dividends are reinvested through a DRIP (Dividend Reinvestment Plan), they purchase additional shares, which then generate their own dividends—creating a compounding effect that can significantly boost long-term returns.
How We Calculate Total Return
Our total return calculator simulates dividend reinvestment (DRIP) by assuming each dividend payment is used to purchase additional shares at the closing price on the ex-dividend date. This methodology provides an accurate representation of how a dividend reinvestment plan would perform.
Frequently Asked Questions
Q1What is the total return of FMS over the past year?
Fresenius Medical Care AG & Co. KGaA (FMS) delivered a total return of 0.15% over the past year when dividends are reinvested. The price-only return was -3.10%, meaning dividends contributed an additional 3.25 percentage points to total returns.
Q2How much would $10,000 invested in FMS be worth today?
A $10,000 investment in Fresenius Medical Care AG & Co. KGaA one year ago would be worth $10,015 today with dividends reinvested (DRIP). Without reinvesting dividends, the same investment would be worth $9,690. Dividend reinvestment added $325 to the portfolio value.
Q3Does FMS pay dividends?
Yes, Fresenius Medical Care AG & Co. KGaA (FMS) pays dividends. In the last year, FMS paid approximately $0.00 per share in dividends. Reinvesting these dividends through a DRIP can significantly boost long-term returns — over 20+ years, dividend compounding can account for 30–50% of total returns for dividend-paying stocks.
Q4Did FMS beat the S&P 500?
No, Fresenius Medical Care AG & Co. KGaA (FMS) underperformed the S&P 500 by 15.30 percentage points over the past year. FMS delivered a total return of 0.15%, compared to the S&P 500's 15.45%. This means a passive S&P 500 index fund outperformed FMS by 15.30pp during this period.
Q5What is FMS's worst drawdown?
Fresenius Medical Care AG & Co. KGaA (FMS) experienced a maximum drawdown of -29.28% over the past year, declining from its peak on 2025-05-20 to its trough on 2026-01-20. The stock has not yet fully recovered to its prior peak. Maximum drawdown measures the worst peak-to-trough decline and is an important risk metric for investors.
Q6What is FMS's long-term total return over 10, 20, or 30 years?
Fresenius Medical Care AG & Co. KGaA (FMS) has delivered strong long-term returns with dividends reinvested. Over 10 years, the total return is -28.5% (-3.3% CAGR) — $10,000 would have grown to $7,149. Over 20 years: 90.8% total return (3.3% CAGR) — $10,000 → $19,082. Over 30 years: 234.8% total return (4.1% CAGR) — $10,000 → $33,475. Long-term investors benefit from compounding: dividends buy additional shares, which generate their own dividends, creating an exponential growth effect.
Q7What was FMS's best and worst year?
Fresenius Medical Care AG & Co. KGaA's best calendar year was 2003 with a total return of 72.5%. Its worst year was 2022 with a total return of -47.7%. This range shows the volatility investors should expect — the difference between the best and worst year is 120.3 percentage points.
Find the Best Dividend Stocks
Screen for dividend stocks with the highest total returns (including DRIP).